Email updates

Keep up to date with the latest news and content from BMC Neurology and BioMed Central.

Open Access Pre-publication history

Rationale and design of a double-blind, placebo-controlled, randomized trial to evaluate the safety and efficacy of nimodipine in preventing cognitive impairment in ischemic cerebrovascular events (NICE)

Penglian Wang, Yongjun Wang*, Tao Feng*, Xingquan Zhao, Yong Zhou, Yilong Wang, Weixiong Shi, Yi Ju and on behalf of the NICE Study Investigators

BMC Neurology 2012, 12:88  doi:10.1186/1471-2377-12-88

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 09 Oct 2011
Reviewer's Report Roberto Federico Villa 01 Jun 2012
Reviewer's Report Svetlana Lorenzano 04 Jun 2012
Reviewer's Report Daniele Tomassoni 15 Jun 2012
Resubmission - Version 2 Manuscript 26 Jul 2012
Resubmission - Version 3 Manuscript Author's comment 26 Jul 2012
Reviewer's Report Roberto Federico Villa 31 Jul 2012
Reviewer's Report Svetlana Lorenzano 13 Aug 2012
Editorial acceptance 27 Aug 2012
Published 05 Sep 2012